Similar articles

• Comparing benefits and harms: the balance sheet.

  Eddy DM. Eddy DM. JAMA. 1990 May 9;263(18):2493, 2498, 2501 passim. doi: 10.1001/jama.263.18.2493. JAMA. 1990. PMID: 2329639 No abstract available.
• Screening for colorectal cancer and prostate cancer: challenges for New Zealand.

  Richardson AK, Potter JD. Richardson AK, et al. N Z Med J. 2014 Jun 6;127(1395):23-30. N Z Med J. 2014. PMID: 24929690 Review.
• [Colorectal carcinoma in the elderly. Our experience].

  Cirilli A, Valerio P, Polizzi RA, Balena V, Punzo C, De Leo G, Fato L, Berardi T. Cirilli A, et al. Minerva Med. 1989 Jul;80(7):705-7. Minerva Med. 1989. PMID: 2779825 Italian. No abstract available.
• Population-based fecal occult blood screening for colon cancer: will the benefits outweigh the harm?

  Marshall KG. Marshall KG. CMAJ. 2000 Sep 5;163(5):545-6; discussion 547. CMAJ. 2000. PMID: 11006766 Free PMC article. No abstract available.
• Colonoscopy as a screening test for colorectal cancer.

  Schapira M, Adler M. Schapira M, et al. Acta Gastroenterol Belg. 2005 Apr-Jun;68(2):251-6. Acta Gastroenterol Belg. 2005. PMID: 16013645 Review.